menu search

Achieve life sciences reports statistically significant smoking cessation benefit for cytisinicline in second, confirmatory phase 3 clinical trial

ORCA-3 demonstrated statistically significant topline results in primary and secondary smoking cessatio...

May 23, 2023, 10:00 am

Achieve life sciences says confirmatory late-stage trial of its treatment for quitting smoking achieved positive results

Achieve Life Sciences Inc. ACHV, +12.88% said Tuesday a second confirmatory late-stage trial of its cytisinicline for quitting smoking and nicotine de...

May 23, 2023, 6:12 am

Novo nordisk says trial of oral weight-loss drug shows significant result

Novo Nordisk's trial of the oral version of its weight-loss drug semaglutide has shown statistically si...

May 22, 2023, 10:22 am

Apnimed presented positive phase 2b results on ad109, an investigational oral drug for obstructive sleep apnea, for the first time at ats 2023

— New MARIPOSA Study Data Showed AD109 statistically Significantly Improved Both Objective and Subjec...

May 21, 2023, 2:00 pm

Travere therapeutics stock slides 35% after announcing disappointing results from 2-year trial of kidney drug

Travere Therapeutics Inc.'s stock TVTX tumbled 35% Tuesday, after the company said data from a two-year study of a kidney drug failed to show a ...

May 2, 2023, 12:50 pm

Merck and eisai report disappointing results from trials of combination treatment for melanoma and colorectal cancer

Merck MRK and its Japanese partner Eisai said Friday they are discontinuing the Phase 3 LEAP-003 trial evaluating Keytruda plus Lenvima for the first-...

April 7, 2023, 7:02 am

Gilead (gild) announces os data on yescarta from zuma-7 study

Gileads Yescarta shows statistically significant improvement in overall survival for initial treatment ...

March 22, 2023, 4:01 pm

Karuna's stock is up after schizophrenia drugs meets primary endpoint in clinical trial

Shares of Karuna Therapeutics Inc. KRTX, +1.21% rallied about 14% in premarket trading on Monday after the company said its experimental treatment for...

March 20, 2023, 7:46 am

Edesa biotech to present favorable dermatitis drug results at american academy of dermatology association annual meeting

TORONTO, ON / ACCESSWIRE / March 16, 2023 / Edesa Biotech, Inc. announced today that the company has been selected to present clinical trial data from...

March 16, 2023, 4:10 pm

Altamira therapeutics to report bentrio clinical data, in house dust mite and grass pollen allergic rhinitis, at feb. 25 aaaai annual meet-ing

House dust mite study shows statistically significant reduction in symptoms vs. no protection Grass pol...

February 14, 2023, 8:47 am

Achieve life sciences: all eyes on phase 3 data for smoking cessation drug

ORCA-2 phase 3 trial was a success where Cytisinicline has shown statistically significant improvement ...

January 28, 2023, 11:45 pm

Atai life sciences shares plummet as r-ketamine candidate fails to meet primary endpoint in phase 2a trial

atai Life Sciences (NASDAQ:ATAI) shares tumbled more than 40% in pre-market trading on Friday after the company reported disappointing results from it...

January 6, 2023, 9:46 am

Moderna shares get a boost from merck vaccine combo

Moderna Therapeutics Inc (NASDAQ:MRNA) shares rallied after the biotechnology firm told investors that a trial that combined its investigational cance...

December 13, 2022, 12:49 pm

Rba says its pandemic cheap lending policy to business failed (sort of)

The Reserve Bank of Australia has published a research paper on its cheap lending facility introduced as part of its Covid policy response. It conc...

December 13, 2022, 3:18 am


Search within

Pages Search Results: